Non-mutational neoantigens in disease

LJ Stern, C Clement, L Galluzzi, L Santambrogio - Nature immunology, 2024 - nature.com
The ability of mammals to mount adaptive immune responses culminating with the
establishment of immunological memory is predicated on the ability of the mature T cell …

Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy

C Moussion, L Delamarre - Seminars in Immunology, 2024 - Elsevier
Dendritic cells (DCs) are professional antigen-presenting cells that play a key role in
shaping adaptive immunity. DCs have a unique ability to sample their environment, capture …

The peptide woods are lovely, dark and deep: Hunting for novel cancer antigens

D Oreper, S Klaeger, S Jhunjhunwala… - Seminars in …, 2023 - Elsevier
Harnessing the patient's immune system to control a tumor is a proven avenue for cancer
therapy. T cell therapies as well as therapeutic vaccines, which target specific antigens of …

[HTML][HTML] Tumor-specific T cells in head and neck cancer have rescuable functionality and can be identified through single-cell co-culture

J Zenga, M Awan, A Frei, J Foeckler, R Kuehn… - Translational …, 2024 - Elsevier
Background Human papillomavirus (HPV)-negative head and neck squamous cell
carcinoma (HNSCC) remains a treatment-resistance disease with limited response to …

Peptide-stimulated T cells bypass immune checkpoint inhibitor resistance and eliminate autologous microsatellite instable colorectal cancer cells

S Schwarz, Z Su, M Krohn, MW Löffler… - NPJ Precision …, 2024 - nature.com
Two hypermutated colon cancer cases with patient-derived cell lines, peripheral and tumor-
infiltrating T cells available were selected for detailed investigation of immunological …

The cryptic immunopeptidome in health and disease

E Kina, JD Larouche, P Thibault, C Perreault - Trends in Genetics, 2024 - cell.com
Peptides presented by MHC proteins regulate all aspects of T cell biology. These MHC-
associated peptides (MAPs) form what is known as the immunopeptidome and their …

Are we getting closer to a successful neoantigen cancer vaccine?

K Manoutcharian, G Gevorkian - Molecular Aspects of Medicine, 2024 - Elsevier
Although significant advances in immunotherapy have revolutionized the treatment of many
cancer types over the past decade, the field of vaccine therapy, an important component of …

Colorectal cancer immunotherapy: state of the art and future directions

AM Cornista, MV Giolito, K Baker, H Hazime, I Dufait… - Gastro hep …, 2023 - Elsevier
Cancer immunotherapy has become an indispensable mode of treatment for a multitude of
solid tumor cancers. Colorectal cancer (CRC) has been one of the many cancer types to …

[HTML][HTML] Generation of colon cancer–derived tumor-infiltrating T cells (TILs) for adoptive cell therapy

HC Albrecht, D Gustavus, J Schwanemann… - Cytotherapy, 2023 - Elsevier
Adoptive cell therapy (ACT) using specific immune cells and stem cells has emerged as a
promising treatment option that could complement traditional cancer therapies in the future …

Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy

W Shao, Y Yao, L Yang, X Li, T Ge, Y Zheng… - … Hematology & Oncology, 2024 - Springer
Adoptive immunotherapy in the T cell landscape exhibits efficacy in cancer treatment. Over
the past few decades, genetically modified T cells, particularly chimeric antigen receptor T …